Daily Market Comment - Are investors sleeping on systematic risk in China?



  • Chinese real estate titan heads for default - will it hit the economy? 
  • Wall Street stages solid comeback, oil keeps going
  • US retail sales to inject some volatility into quiet FX market 
Markets downplay China contagion

It’s time to talk about China. The situation is getting dicier as the nation’s second-largest property developer - Evergrande - is on the verge of default. Trading in the company’s onshore bonds was suspended today, which is usually a prelude to bankruptcy. Its total liabilities boil down to around $300bn, or 2% of China’s GDP. 

Now that doesn’t sound dramatic, but it is when leverage comes into play. China’s real estate sector accounts for nearly one-third of the entire economy while the banking sector is currently almost three times as large as GDP, which means banks are levered up to the brim with private debt. 

So you have a vulnerable system with tremendous private debt and banking leverage, and now a company that was flagged by the Chinese central bank back in 2018 as posing systematic risks to the entire economy is about to default. It’s easy to imagine a domino effect that ripples through markets as financial institutions that have exposure to Evergrande suffer serious damage. 

Of course, Beijing won’t let that happen. The private sector might be drowning in debt but the government has plenty of dry powder and cards to play - it could stop any domino effect at its root by bailing out the most fragile players. 

But when you combine the fragility in the Chinese system with signs that economic momentum is already crumbling and the regulatory crusade that Beijing has embarked on, it’s one risk too many. Policymakers might be able to stop a default cascade, but they can’t revive growth without making the nation’s leverage problem even worse. 

This might be the most dangerous ‘grey swan’ event for the global economy right now. The fallout has been contained to stock markets in China and Hong Kong so far, but if the situation deteriorates any further, the next levee to break might be China-sensitive currencies like the Australian and New Zealand dollars. 

Wall Street bounces back, oil advances

Over in America, Wall Street ended with broad gains on Wednesday, with the S&P 500 rising nearly 0.9%. The 50-day moving average worked its magic once again as the index recoiled higher after it tested that crucial indicator. There wasn’t much in terms of news to pin the move on. 

President Biden met with Manchin and Sinema yesterday - the two most conservative Democrats in the Senate - in an attempt to secure their support for his transformative $3.5 trillion spending bill. He is clearly allocating most of his political capital to this spending package. This bill is a double-edged sword for the market as with great social spending also comes a greater tax burden, most notably on corporations and capital gains. 

Elsewhere, oil prices remain in an upward trajectory, capitalizing on another drawdown in US inventories and the aftermath of the recent hurricanes. 

US retail sales to cool, Australian dollar struggles

As for today, all eyes will be on the latest edition of US retail sales. Forecasts point to a second straight month of declines, which sounds worrisome, especially considering the sharp decline in consumer confidence metrics lately. 

That said, the retail sales uptrend this year has been absolutely stunning, so a minor retreat is more than natural. It wouldn’t be a sign that the US consumer is rolling over, but rather that things are normalizing. Hence, any disappointment might not hurt the dollar much, especially if investors seek shelter from the brewing China storm in the reserve currency. 

Finally, the aussie is under pressure today after some disappointing jobs data. The unemployment rate only fell because labor force participation collapsed, which suggests people aren’t actively looking for work during lockdowns. 

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.